1Godoy-M：tos AF, Vaisman F, Pedrosa AP, et al. Central- to-peripheral fat ratio, but not peripheral body fat, is relat- ed to insulin resistance and androgen markers in polycys- tic ovary syndrome [ J ]. Gynecol Endocrinol, 2009, 25 (12) :793-798.
2Cosar E, Ucok K, Akgun L, et al. Body fat composition and distribution in women with polycystic ovary syndrome[ J]. Gynecol Endocrinol,2008,24 (8) :428-432.
3Ibanez L, de Zegher F. Ethinylestradiol-drospirenone, flu- tamide-met-formin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity [ J ]. J Clin Endocri- nol Metab, 2004,89 (4) : 1592-1597.
4Ibanez L, de Zegher F. Flutamide-mefformin plus ethi- nylestradiol-dro-spirenone for lipolysis and antiatherogen- esis in young women with ovarian hyperandrogenism:the key role of mefformin at the start and after more than oneyear of therapy [ J ]. J Clin Endoerinol Metab, 2005,90 (1) :39-43.
5Moro C, Pasariea M, Elkind-Hirsch K, et al. Aerobic Exer- cise Training Improves Atrial Natriuretic Peptide and Cat- echolamine-Mediated Lipolysis in Obese Women with Polycystic Ovary Syndrome [ J ]. J Clin Endocrinol Metab, 2009,94(7) :2579-2586.
6Chang W, Goodarzi MO, Williams H, et al. Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3 [ J ]. Fertil Steril, 2008,90 (6) :2291-2297.
7Corbould A, Dunaif A. The adipose cell lineage is not in- trinsically insulin resistant in polycystic ovary syndrome [ J ]. Metab Olin Exp, 2007,56 ( 5 ): 716-722.
8Corbould A. Chronic testosterone treatment induces selec- tive insulin resistance in subcutaneous adipocytes of women [ J ]. J Endocrlnol, 2007,192 ( 3 ) : 585,594.
9Arner P. Effects of testosterone on fat cell lipolysis. Spe- cies differences and possible role in polycystic ovarian syndrome [ J ]. Biochimie. 2005,87 ( 1 ) :39-43.
10McInnes KJ, Corbould A, Simpson ER, et al. Regulation of adenosine 5 "-monophosphate-activated protein ki-nase and lipogenesis by androgens contributes to visceral obe- sity in an estrogen-deficient state [ J ]. Endoerino1,2006, 147 (12) :5907-5913.
8Zhao WQ, Townsend M.Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer' s disease[J].Biochimica biophysica acta, 2009, 1792 (5) :482-496.
9Beurel E, Michalek SM, Jope RS.Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3) [J]. Trends in immunology, 2010, 31 ( 1 ) :24-31.
10Benzler J, Ganjam GK, Kruger M, et al.Hypothalamic glycogen synthase kinase 313 has a central role in the regulation of food intake and glucose metabolism[J].The Biochemical Journal, 2012, 447 ( 1 ): 175-184.
